Benign symmetric lipomatosis

Last updated
Benign symmetric lipomatosis
Other namesBenign symmetric lipomatosis of Launois–Bensaude; Madelung's disease; multiple symmetric lipomatosis; cephalothoracic lipodystrophy; symmetrical adenolipomatosis; fat neck (Fetthals)
Benign symmetric lipomatosis.JPG
A young man with benign symmetric lipomatosis (Madelung's disease) of unknown cause exhibiting Madelung's collar and buffalo hump
Specialty Dermatology, endocrinology
Usual onsetAdult-onset

Benign symmetric lipomatosis, also known as Madelung's disease, is an adult-onset skin condition characterized by extensive symmetric fat deposits in the head, neck, and shoulder girdle area. [1] The symmetrical fat deposits are made of unencapsulated lipomas, which distinguishes it from typical lipomatosis which has encapsulated lipomas that are not usually symmetrical. [2] Benjamin Brodie described the condition in 1846. The German surgeon Otto Wilhelm Madelung was the first to give a detailed description of the disorder in 1888, followed by Launois and Bensaude in 1898. [3]

Contents

This condition is rare, with an estimated incidence of 1 in 25,000 in Italy. [3] [4] Older research found that it affects males up to 15 - 30 times more frequently than females; [3] [4] however, more recent studies have found a higher prevalence among women than men (1:2.5) and so further epidemiological studies are needed. [4] It predominantly affects those of the Mediterranean and European populations, although rare cases have been documented outside of those populations [5] (such as Ethiopian, [6] Chinese, [7] Mexican-American, [8] Indian, [2] African-American, [9] and African-Indian [10] ).

Large fat deposits around the neck, and more rarely in the tongue, may negatively affect breathing, swallowing, and speaking. [11] [12] Orbital involvement is very rare, with proptosis (bulging of the eye) and persistent bilateral lumps on the eyelids. [13] [14]

Comorbidities frequently involve the endocrine systems, with hypercholesterinemia and hypothyroidism being the most common. [13] [4] Other comorbidities include diabetes mellitus, hypertension, and gout. [5] [4] In individuals with alcohol use disorder, there is also alcohol-related cirrhosis of the liver. [5] [4] There have also been reports of peripheral neuropathy, ragged red fibres in muscle cells (suggesting mitochondrial myopathy), sudden cardiac death, and neurological involvement, although it is unknown whether these are due to prolonged alcohol use disorder as such symptoms of mitochondrial dysfunction also appear in alcoholics without Madelung's disease. [5] [4] [15] [16] However, rarely, instances of mitochondrial dysfunction (high lactate/low pyruvate, polyneuropathy, decreased cytochrome c oxidase and abnormal mitochondria) have been documented in non-alcoholics with Madelung's disease. [2] [15] [16]

Cosmetic disfigurement due to the fat deposition in the cervicothoracic region results in a "pseudoathletic appearance," resembling the Italian statue Warrior of Capestrano and carvings of Queen of Punt (Egypt). [10] [17] The fat deposited around the front of the neck is known as Madelung's collar or horse collar. [13] [5] Fat deposited on the back of the neck between the shoulder blades is known as a dorsocervical fat pad or buffalo hump. [13] [18] Fat deposited in the parotid region is known as hamster cheeks. [10]

Cause

The cause of the disease remains unknown, but its incidence strongly correlates with alcohol use disorder (over 90% of cases); in such cases, abstinence from alcohol prevents disease progression. Defects in the adrenergic-stimulated lipolysis and accumulation of embryological brown fat have also been reported. [10]

Types

Earlier, the disease was classified by G. Enzi and others into two types: [4]

In 1991, Donhauser classified the disease into four types, which subsequently became a commonly accepted classification: [4]

In 2018, a new classification was proposed, as most of the patients in the largest German study of that time did not reliably fit into the Donhauser classification system. Schiltz and others at the University Hospital Regensburg proposed the disease to be classified into five types: [4]

Treatment

Traditionally the treatment is mainly surgical, consisting of the removal of the lipomas (lipectomy), although recent study has proposed liposuction and phosphatidylcholine injection as possible alternatives. [19]

Society

The appearance of people with the disease is depicted in:

See also

Related Research Articles

<span class="mw-page-title-main">Lipoma</span> Benign tumor made of fat tissue

A lipoma is a benign tumor made of fat tissue. They are generally soft to the touch, movable, and painless. They usually occur just under the skin, but occasionally may be deeper. Most are less than 5 cm (2.0 in) in size. Common locations include upper back, shoulders, and abdomen. It is possible to have several lipomas.

<span class="mw-page-title-main">Limb–girdle muscular dystrophy</span> Medical condition

Limb–girdle muscular dystrophy (LGMD) is a genetically heterogeneous group of rare muscular dystrophies that share a set of clinical characteristics. It is characterised by progressive muscle wasting which affects predominantly hip and shoulder muscles. LGMD usually has an autosomal pattern of inheritance. It currently has no known cure or treatment.

<span class="mw-page-title-main">Benign tumor</span> Mass of cells which cannot spread throughout the body

A benign tumor is a mass of cells (tumor) that does not invade neighboring tissue or metastasize. Compared to malignant (cancerous) tumors, benign tumors generally have a slower growth rate. Benign tumors have relatively well differentiated cells. They are often surrounded by an outer surface or stay contained within the epithelium. Common examples of benign tumors include moles and uterine fibroids.

<span class="mw-page-title-main">Polymyalgia rheumatica</span> Medical condition

Polymyalgia rheumatica (PMR) is a syndrome experienced as pain or stiffness, usually in the neck, shoulders, upper arms, and hips, but which may occur all over the body. The pain can be sudden or can occur gradually over a period. Most people with PMR wake up in the morning with pain in their muscles; however, cases have occurred in which the person has developed the pain during the evenings or has pain and stiffness all day long.

<span class="mw-page-title-main">Hamartoma</span> Tumour-like overgrowth due to a systemic genetic condition

A hamartoma is a mostly benign, local malformation of cells that resembles a neoplasm of local tissue but is usually due to an overgrowth of multiple aberrant cells, with a basis in a systemic genetic condition, rather than a growth descended from a single mutated cell (monoclonality), as would typically define a benign neoplasm/tumor. Despite this, many hamartomas are found to have clonal chromosomal aberrations that are acquired through somatic mutations, and on this basis the term hamartoma is sometimes considered synonymous with neoplasm. Hamartomas are by definition benign, slow-growing or self-limiting, though the underlying condition may still predispose the individual towards malignancies.

<span class="mw-page-title-main">Cowden syndrome</span> Medical condition

Cowden syndrome is an autosomal dominant inherited condition characterized by benign overgrowths called hamartomas as well as an increased lifetime risk of breast, thyroid, uterine, and other cancers. It is often underdiagnosed due to variability in disease presentation, but 99% of patients report mucocutaneous symptoms by age 20–29. Despite some considering it a primarily dermatologic condition, Cowden's syndrome is a multi-system disorder that also includes neurodevelopmental disorders such as macrocephaly.

<span class="mw-page-title-main">Mitochondrial myopathy</span> Medical condition

Mitochondrial myopathies are types of myopathies associated with mitochondrial disease. Adenosine triphosphate (ATP), the chemical used to provide energy for the cell, cannot be produced sufficiently by oxidative phosphorylation when the mitochondrion is either damaged or missing necessary enzymes or transport proteins. With ATP production deficient in mitochondria, there is an over-reliance on anaerobic glycolysis which leads to lactic acidosis either at rest or exercise-induced.

<span class="mw-page-title-main">Lipomatosis</span> Medical condition

Lipomatosis is believed to be an autosomal dominant condition in which multiple lipomas are present on the body. Many discrete, encapsulated lipomas form on the trunk and extremities, with relatively few on the head and shoulders. In 1993, a genetic polymorphism within lipomas was localized to chromosome 12q15, where the HMGIC gene encodes the high-mobility-group protein isoform I-C. This is one of the most commonly found mutations in solitary lipomatous tumors but lipomas often have multiple mutations. Reciprocal translocations involving chromosomes 12q13 and 12q14 have also been observed within.

Dercum's disease is a rare condition characterized by multiple painful fatty tumors, called lipomas, that can grow anywhere in subcutaneous fat from scalp to plantar surface of the foot. Sometimes referred as adiposis dolorosa in medical literature, Dercum’s disease is more of a syndrome than a disease. While the term adiposis dolorosa may be correct, the term Dercum's disease is more often used, along with the acronym DD.

Injection lipolysis is a controversial cosmetic procedure in which drug mixtures are injected into patients with the goal of destroying fat cells. This practice, using drugs generally based on phosphatidylcholine and deoxycholate (PCDC), evolved from the initial intravenous use of those drug formulations to treat blood disorders.

<span class="mw-page-title-main">Otto Wilhelm Madelung</span> German surgeon (1846–1926)

Otto Wilhelm Madelung was a German surgeon who was a native of Gotha. His son, physicist Erwin Madelung (1881–1972), discovered the Madelung constant.

<span class="mw-page-title-main">Frontonasal dysplasia</span> Medical condition

Frontonasal dysplasia (FND) is a congenital malformation of the midface. For the diagnosis of FND, a patient should present at least two of the following characteristics: hypertelorism, a wide nasal root, vertical midline cleft of the nose and/or upper lip, cleft of the wings of the nose, malformed nasal tip, encephalocele or V-shaped hair pattern on the forehead. The cause of FND remains unknown. FND seems to be sporadic (random) and multiple environmental factors are suggested as possible causes for the syndrome. However, in some families multiple cases of FND were reported, which suggests a genetic cause of FND.

<span class="mw-page-title-main">Hibernoma</span> Medical condition

A hibernoma is a benign neoplasm of vestigial brown fat. The term was originally used by the French anatomist Louis Gery in 1914.

Neural fibrolipoma is an overgrowth of fibro-fatty tissue along a nerve trunk that often leads to nerve compression. These only occur in the extremities, and often affect the median nerve. They are rare, very slow-growing, and their origin is unknown. It is believed that they may begin growth in response to trauma. They are not encapsulated by any sort of covering or sheath around the growth itself, as opposed to other cysts beneath the skin that often are. This means there are loosely defined margins of this lipoma. Despite this, they are known to be benign. Neural fibrolipomas are often more firm and tough to the touch than other lipomas. They are slightly mobile under the skin, and compress with pressure.

<span class="mw-page-title-main">Mammary-type myofibroblastoma</span> Medical condition

Mammary-type myofibroblastoma (MFB), also named mammary and extramammary myofibroblastoma, was first termed myofibrolastoma of the breast, or, more simply, either mammary myofibroblastoma (MMFB) or just myofibroblastoma. The change in this terminology occurred because the initial 1987 study and many subsequent studies found this tumor only in breast tissue. However, a 2001 study followed by numerous reports found tumors with the microscopic histopathology and other key features of mammary MFB in a wide range of organs and tissues. Further complicating the issue, early studies on MFB classified it as one of various types of spindle cell tumors that, except for MFB, were ill-defined. These other tumors, which have often been named interchangeably in different reports, are: myelofibroblastoma, benign spindle cell tumor, fibroma, spindle cell lipoma, myogenic stromal tumor, and solitary stromal tumor. Finally, studies suggest that spindle cell lipoma and cellular angiofibroma are variants of MFB. Here, the latter two tumors are tentatively classified as MFB variants but otherwise MFB is described as it is more strictly defined in most recent publications. The World Health Organization in 2020 classified mammary type myofibroblastoma tumors and myofibroblastoma tumors as separate tumor forms within the category of fibroblastic and myofibroblastic tumors.

Encephalocraniocutaneous lipomatosis (ECCL), is a rare condition primarily affecting the brain, eyes, and skin of the head and face. It is characterized by unilateral subcutaneous and intracranial lipomas, alopecia, unilateral porencephalic cysts, epibulbar choristoma and other ophthalmic abnormalities. This condition is described as sporadic because it occurs in people without a history of the disorder in their family.

<span class="mw-page-title-main">Familial multiple lipomatosis</span> Hereditary adipose tissue disorder

Familial multiple lipomatosis is a hereditary adipose tissue disorder that is characterized by the formation of multiple lipomas that occur in a particular distribution. The lipomas are well-encapsulated, slow-growing, benign fatty tumors. The distribution is defined as being focused in the trunk of the body and extremities. Familial Multiple Lipomatosis can be identified when multiple lipomas occur in multiple family members that span different generations. Some people may have hundreds of lipomas present.

<span class="mw-page-title-main">Calpainopathy</span> Medical condition

Calpainopathy is the most common type of autosomal recessive limb-girdle muscular dystrophy (LGMD). It preferentially affects the muscles of the hip girdle and shoulder girdle.

<span class="mw-page-title-main">Pseudohypertrophy</span> False enlargement of muscle due to infiltration of fat or other tissue

Pseudohypertrophy, or false enlargement, is an increase in the size of an organ due to infiltration of a tissue not normally found in that organ. It is commonly applied to enlargement of a muscle due to infiltration of fat or connective tissue, famously in Duchenne muscular dystrophy. This is in contrast with typical muscle hypertrophy, in which the muscle tissue itself increases in size. Because pseudohypertrophy is not a result of increased muscle tissue, the muscles look bigger but are actually atrophied and thus weaker. Pseudohypertrophy is typically the result of a disease, which can be a disease of muscle or a disease of the nerve supplying the muscle.

<span class="mw-page-title-main">Pseudoathletic appearance</span> Medical sign

Pseudoathletic appearance is a medical sign meaning to have the false appearance of a well-trained athlete due to pathologic causes instead of true athleticism. It is also referred to as a Herculean or bodybuilder-like appearance. It may be the result of muscle inflammation, muscle hyperplasia, muscle hypertrophy, muscle pseudohypertrophy, or symmetrical subcutaneous deposits of fat or other tissue.

References

  1. Rapini, Ronald P.; Bolognia, Jean L.; Jorizzo, Joseph L. (2007). Dermatology: 2-Volume Set. St. Louis: Mosby. ISBN   978-1-4160-2999-1.
  2. 1 2 3 Suresh Chandran, C. J.; Godge, Y. R.; Oak, P. J.; Ravat, S. H. (April 2009). "Madelung's disease with myopathy". Annals of Indian Academy of Neurology. 12 (2): 131–132. doi: 10.4103/0972-2327.53086 . ISSN   1998-3549. PMC   2812741 . PMID   20142863.
  3. 1 2 3 González-García R, Rodríguez-Campo FJ, Sastre-Pérez J, Muñoz-Guerra MF (2004). "Benign symmetric lipomatosis (Madelung's disease): case reports and current management". Aesthetic Plast Surg. 28 (2): 108–12, discussion 113. doi:10.1007/s00266-004-3123-5. PMID   15164232. S2CID   45300059.
  4. 1 2 3 4 5 6 7 8 9 10 Schiltz, Daniel; Anker, Alexandra; Ortner, Christine; Tschernitz, Sebastian; Koller, Michael; Klein, Silvan; Felthaus, Oliver; Schreml, Julia; Schreml, Stephan; Prantl, Lukas (April 2018). "Multiple Symmetric Lipomatosis: New Classification System Based on the Largest German Patient Cohort". Plastic and Reconstructive Surgery. Global Open. 6 (4): e1722. doi:10.1097/GOX.0000000000001722. ISSN   2169-7574. PMC   5977945 . PMID   29876171.
  5. 1 2 3 4 5 "Madelung's Disease". NORD (National Organization of Rare Disorders).
  6. Zewde, Yared Zenebe (2021-07-03). "Madelung's disease in a non-alcoholic Ethiopian male patient mistaken for obesity: a case report". BMC Endocrine Disorders. 21 (1): 142. doi: 10.1186/s12902-021-00803-9 . ISSN   1472-6823. PMC   8254943 . PMID   34217263.
  7. Wanke, Jin; Yongjing, Fan (February 2022). "A case report of Madelung's disease in China". Radiology Case Reports. 17 (2): 320–325. doi:10.1016/j.radcr.2021.10.035. ISSN   1930-0433. PMC   8633830 . PMID   34876958.
  8. "Madelung's Disease with polyneuropathy in a non-alcoholic Mexican-American male". www.oatext.com. Retrieved 2023-10-22.
  9. Sarhill, N.; Kumar, Ajay; Cook, L.; Tahir, A.; Barakat, K. (2006). "Madelung's Disease in an African-American Patient". S2CID   78759779.{{cite journal}}: Cite journal requires |journal= (help)
  10. 1 2 3 4 5 Medappil Noushif; Vasu TA (July 2010). "Madelung's disease: A spot diagnosis". Indian J Plast Surg. 43 (2): 227–8. doi: 10.4103/0970-0358.73472 . PMC   3010793 . PMID   21217991.
  11. Louza, Guilherme Felix; Zanetti, Gláucia; Marchiori, Edson (August 2022). "Madelung's Disease: A Rare Cause of Dyspnea". Archivos de Bronconeumologia. 58 (8): 612. doi:10.1016/j.arbres.2021.09.015. ISSN   1579-2129. PMID   35312558. S2CID   241472327.
  12. Lopez-Ceres, Ana; Aguilar-Lizarralde, Yolanda; Villalobos Sánchez, Aurora; Prieto Sánchez, Elisa; Valiente Alvarez, Antonio (December 2006). "Benign symmetric lipomatosis of the tongue in Madelung's disease". Journal of Cranio-Maxillo-Facial Surgery. 34 (8): 489–493. doi:10.1016/j.jcms.2006.06.003. ISSN   1010-5182. PMID   17157517.
  13. 1 2 3 4 Şükün, Abdullah; Demirci, Mehmet Fatih; Akbay, Ertan (June 2023). "Type 1C Multiple Symmetrical Lipomatosis: A Cause of Misdiagnosis in Females". Cureus. 15 (6): e40970. doi: 10.7759/cureus.40970 . ISSN   2168-8184. PMC   10370365 . PMID   37503462.
  14. Lumyongsatien, Mingkwan; Selva, Dinesh (April 2022). "Bilateral symmetric lipomatosis of the orbit in Madelung's disease". Orbit (Amsterdam, Netherlands). 41 (2): 268–270. doi:10.1080/01676830.2020.1852261. ISSN   1744-5108. PMID   33243058. S2CID   227182356.
  15. 1 2 Klopstock, T.; Naumann, M.; Schalke, B.; Bischof, F.; Seibel, P.; Kottlors, M.; Eckert, P.; Reiners, K.; Toyka, K. V.; Reichmann, H. (May 1994). "Multiple symmetric lipomatosis: abnormalities in complex IV and multiple deletions in mitochondrial DNA". Neurology. 44 (5): 862–866. doi:10.1212/wnl.44.5.862. ISSN   0028-3878. PMID   8190288. S2CID   2474345.
  16. 1 2 Naumann, M.; Schalke, B.; Klopstock, T.; Reichmann, H.; Lange, K. W.; Wiesbeck, G.; Toyka, K. V.; Reiners, K. (July 1995). "Neurological multisystem manifestation in multiple symmetric lipomatosis: a clinical and electrophysiological study". Muscle & Nerve. 18 (7): 693–698. doi:10.1002/mus.880180704. ISSN   0148-639X. PMID   7783758. S2CID   27498996.
  17. Miraglia, E.; Moliterni, E.; Iacovino, C.; Chello, C.; Laghi, A.; Giustini, S. (2021-05-05). "Madelung's disease. Two case reports with pseudoathletic appearance". La Clinica Terapeutica. 172 (3): 190–192. doi:10.7417/CT.2021.2311. ISSN   1972-6007. PMID   33956034.
  18. Liu, S -Z; Zhou, X; Wang, Y -P; Liu, Y; Song, A (2019-06-26). "The Madelung's disease and the buffalo hump sign". QJM: An International Journal of Medicine. 113 (3): 219. doi: 10.1093/qjmed/hcz160 . ISSN   1460-2725. PMID   31250017.
  19. Hasegawa T, Matsukura T, Ikeda S (June 2009). "Mesotherapy for Benign Symmetric Lipomatosis". Aesthetic Plast Surg. 34 (2): 153–6. doi:10.1007/s00266-009-9374-4. PMID   19488808. S2CID   1678529.
  20. Leon, Donna (2012). Beastly Things (Commissario Brunetti, #21) . Grove/Atlantic. p.  5 of Chapter 3. ISBN   978-0802120236.